Contact Us

Experimental drug slows progression of Alzheimer’s: Study

An experimental Alzheimer's drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of serious side effects for certain patients, according to detailed data presented on Tuesday.

  • 8
  • 8
Currently, more than 55 million people live with dementia worldwide, and this number is estimated to reach 78 million by 2030 and 139 million by 2050, according to the World Health Organization.